Navigation Links
Journal Chest: April news briefs
Date:4/7/2009

ASTHMA EPISODES DECREASE WITH REDUCED ETS EXPOSURE

Environmental tobacco smoke (ETS) exposure is associated with poor asthma outcomes in children. However, a new study shows that reducing exposure to ETS may improve asthma outcomes. University of Alabama researchers followed 240 children with asthma who were either receiving usual care or supervised asthma therapy. No smoking cessation counseling or ETS exposure education was provided to caregivers; however, children were given 20 minutes of asthma education that incorporated discussion on the avoidance of asthma triggers, including ETS. Asthma morbidity and ETS exposure were collected from caregivers via telephone interviews at baseline and at 1-year follow-up. Among children whose ETS exposure decreased from baseline, fewer hospitalizations and ED visits were reported. Additionally, these children were 48 percent less likely to experience an episode of poor asthma control. These findings emphasize the importance of ETS exposure reduction as a mechanism to improve asthma control and morbidity. This study is published in the April issue of the journal CHEST.

FOOT SURGERY PATIENTS RUN LOW RISK FOR BLOOD CLOTS

Although recent surgery is a risk factor for deep vein thrombosis (DVT) or blood clots, a new study suggests that patients who undergo podiatric surgery may have a relatively low risk for thrombolytic events. In a 5-year retrospective analysis, researchers from Kaiser Permanente Center for Health Research reviewed the charts of 7,264 patients who underwent podiatric surgical procedures. Of the 16,804 total procedures recorded, overall incidence of post-procedure venous thromboembolism (VTE) was 0.30 percent. The incidence of VTE increased slightly with the presence of risk factors, including prior VTE, use of hormone replacement therapy, and obesity. Researchers conclude that the low overall risk of VTE in podiatric surgery suggests routine prophylaxis is not warranted. This study is published in the April issue of the journal CHEST.

RARE LUNG DISEASE PREVALENT IN TENNESSEE APPALACHIA

New research confirms that blastomycosis, an uncommon lung disease caused by a fungus, continues to be a problem in the Appalachian area of northeastern Tennessee. The disease, characterized by flu-like symptoms, is most often reported in people with exposures to wooded sites (e.g., farmers, forestry workers, hunters, and campers). In a retrospective study, researchers from East Tennessee State University found that blastomycosis was still prevalent in the northeastern Tennessee area (n=67), increasing slightly from the research team's previous findings from 1980 to 1995 (n=55). Researchers speculate that, as the region continues to experience a population growth, additional cases of the disease are to be expected. This study is published in the April issue of the journal CHEST.


'/>"/>

Contact: Jennifer Stawarz
847-498-8306
American College of Chest Physicians
Source:Eurekalert

Related medicine news :

1. Medical Journal Praises VA Electronic Health Record
2. Foundation for Biomedical Research Announces Michael E. DeBakey Journalism Awards
3. In Five-Part Video Series, Yoga Journal Hires The Inappropriate Yoga Guy as Editor
4. Cardiums InnerCool Announces Journal of Neurotrauma Highlights Hypothermia Therapys Role in Post Cardiac Arrest, and Traumatic Brain and Spinal Cord Injury Patients
5. Response to Association Between Hospital-Reported Leapfrog Safe Practices Scores and Inpatient Mortality, Journal of the American Medical Association (JAMA); April 1, 2009
6. Pathwork Tissue of Origin Test Validation Study Published in Journal of Clinical Oncology
7. New Report In The Journal of Nutrition Shows Soy Is Beneficial For Heart and Bone Health
8. Prime Pharmacists Recognized by the Journal of Managed Care Pharmacy
9. U of Minnesota professor authors report the state of health care journalism
10. Journal of American College of Surgeons finds lung transplantation should be used in older patients
11. Journal Chest: March news briefs
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/13/2017)... ... October 13, 2017 , ... The American Board of Family Medicine's (ABFM) Board ... Chief Executive Officer, succeeding Dr. James C. Puffer upon his retirement. Dr. Newton will ... Dr. Puffer’s retirement at the end of 2018. Upon assuming the role of President ...
(Date:10/13/2017)... ... October 13, 2017 , ... Lori R. Somekh, founder of the ... a national organization of elder law and special needs planning attorneys. “Membership in ElderCounsel ... also provides a forum to network with elder law attorneys nationwide,” said Somekh. ...
(Date:10/13/2017)... ... October 13, 2017 , ... Ellevate Network, the leading network ... advocate for action towards gender equality at their inaugural Summit in New York City ... and reached a social audience of over 3 million. To watch the Mobilize Women ...
(Date:10/13/2017)... ... October 13, 2017 , ... ... Software Development, has been awarded a contract by the Center for Medicare and ... aims to accelerate the enterprise use of Agile methodologies in a consistent and ...
(Date:10/12/2017)... Francisco, CA (PRWEB) , ... October 12, 2017 ... ... Dr. Cheng, are now treating sleep apnea using cutting-edge Oventus O2Vent ... apnea, a serious sleep disorder characterized by frequent cessation in breathing. Oral appliances ...
Breaking Medicine News(10 mins):
(Date:9/27/2017)... , Sept. 27, 2017  Commended for their devotion ... notable awards. Ranked as number one in the South Florida ... time in Inc. 5000 yearly list, the national specialty pharmacy ... Armando Bardisa will soon be honored by SFBJ ... Set to receive his award in ...
(Date:9/25/2017)... AMSTERDAM , Sept. 25, 2017   ... Trial Master File solutions, today—from the IQPC Trial ... Amsterdam , NL)—announced that EastHORN Clinical Services ... its clinical programs and TMF management. EastHORN, a ... Montrium,s eTMF platform to increase transparency to enable ...
(Date:9/23/2017)... , Sept. 22, 2017 Janssen Biotech, Inc. ... response letter from the U.S. Food and Drug Administration ... of sirukumab for the treatment of moderately to severely ... additional clinical data are needed to further evaluate the ... severely active RA. ...
Breaking Medicine Technology: